The frequency of uveitis in children is relatively low, approximately 8% of all cases of uveitis occurring in children under the age of 16.' Large series of patients with uveitis have been described by Kimura and Hogan,2 by Perkins,3 and by Jutte et al.4 In children, juvenile rheumatoid arthritis (JRA), also known as Still's disease, is the most common systemic association of chronic uveitis. Of 340 cases of systemic uveitis in childhood Kanski and Shun-Shin' found that 277 cases were associated with JRA. Juvenile ankylosing spondylitis (46 patients), juvenile psoriatic arthritis (nine patients), sarcoidosis (three patients), tuberculosis, Reiter's syndrome (one patient) and the Voght-Koyanagi-Harada syndrome (one patient) were the other underlying systemic disorders. Specific uveitis entities unassociated with a systemic disorder include pars planitis, Fuch's heterochromic cyclitis, and juvenile chronic iridocyclitis. ' In chronic anterior uveitis the anterior chamber reaction is often not gross but can persist for years. In most cases the onset is insidious and the disease is only discovered when the child is noted to have a difference in colour between the two eyes, a difference in the shape of the pupil, the onset of strabismus, or a white mark on the pupil or the cornea. Some are detected when being examined routinely after the diagnosis of arthritis is made.7 Seventy per cent are bilaterally affected and 75% of the patients with JRA and uveitis are girls. 8 Chronic uveitis in children often results in band keratopathy, cataracts, vitreous opacities, macular oedema and pucker, and glaucoma which, alone or in concert, progressively and insidiously impair vision.
Before starting treatment an underlying disorder should be excluded. It is preferable not to start systemic steroids before any immunological investigations are undertaken especially where tuberculosis and sarcoidosis may be suspected.
Steroids are still the mainstay of the management of uveitis. Though the chronic anterior uveitis can persist for many years in most cases it can be at least partly controlled by topical, periocular, or systemic steroids. Mydriatics may prevent but will rarely break down the posterior synechiae. It is usually best to give short acting mydriatic drops; they can, especially before synechiae have formed, be used at night causing fewer problems from the cycloplegia and mydriasis. The severe side effects of prolonged systemic steroids have often been the reason for using cytotoxic drugs in particularly severe cases of uveitis in adults: Dinning9 however felt they should not be used in children. Martenet 
